Topiramate-induced macular neurosensory retinal detachment

PURPOSE: To present a previously unreported retinal side-effect from topiramate use in two cases. OBSERVATIONS: Macular neurosensory retinal detachments were seen in two patients shortly after beginning oral topiramate. The macular detachments resolved shortly after discontinuing this medication. CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Kevin, Maguire, Joseph, Benevento, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722185/
https://www.ncbi.nlm.nih.gov/pubmed/29260075
http://dx.doi.org/10.1016/j.ajoc.2017.05.005
_version_ 1783284968640741376
author Rosenberg, Kevin
Maguire, Joseph
Benevento, Joseph
author_facet Rosenberg, Kevin
Maguire, Joseph
Benevento, Joseph
author_sort Rosenberg, Kevin
collection PubMed
description PURPOSE: To present a previously unreported retinal side-effect from topiramate use in two cases. OBSERVATIONS: Macular neurosensory retinal detachments were seen in two patients shortly after beginning oral topiramate. The macular detachments resolved shortly after discontinuing this medication. CONCLUSIONS AND IMPORTANCE: As these two cases represent the first reports of topiramate-induced macular neurosensory retinal detachment, clinicians should be aware of this potential ocular side effect when administering this medication.
format Online
Article
Text
id pubmed-5722185
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57221852017-12-19 Topiramate-induced macular neurosensory retinal detachment Rosenberg, Kevin Maguire, Joseph Benevento, Joseph Am J Ophthalmol Case Rep Case report PURPOSE: To present a previously unreported retinal side-effect from topiramate use in two cases. OBSERVATIONS: Macular neurosensory retinal detachments were seen in two patients shortly after beginning oral topiramate. The macular detachments resolved shortly after discontinuing this medication. CONCLUSIONS AND IMPORTANCE: As these two cases represent the first reports of topiramate-induced macular neurosensory retinal detachment, clinicians should be aware of this potential ocular side effect when administering this medication. Elsevier 2017-05-19 /pmc/articles/PMC5722185/ /pubmed/29260075 http://dx.doi.org/10.1016/j.ajoc.2017.05.005 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case report
Rosenberg, Kevin
Maguire, Joseph
Benevento, Joseph
Topiramate-induced macular neurosensory retinal detachment
title Topiramate-induced macular neurosensory retinal detachment
title_full Topiramate-induced macular neurosensory retinal detachment
title_fullStr Topiramate-induced macular neurosensory retinal detachment
title_full_unstemmed Topiramate-induced macular neurosensory retinal detachment
title_short Topiramate-induced macular neurosensory retinal detachment
title_sort topiramate-induced macular neurosensory retinal detachment
topic Case report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722185/
https://www.ncbi.nlm.nih.gov/pubmed/29260075
http://dx.doi.org/10.1016/j.ajoc.2017.05.005
work_keys_str_mv AT rosenbergkevin topiramateinducedmacularneurosensoryretinaldetachment
AT maguirejoseph topiramateinducedmacularneurosensoryretinaldetachment
AT beneventojoseph topiramateinducedmacularneurosensoryretinaldetachment

Ejemplares similares